Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt ...

FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for ...

With that prospect in mind, there are a few best practices pharma brands should follow ... Instead of leading with a brand name and logo, DiBona said drugmakers should opt to create relevant content ...

A small Border village in South Tyrone is not usually where you’d expect to find Northern Ireland’s first state-of-the-art ...

Is it even 2025 if you’re not rethinking your crypto game? Forget the coins you missed. This new cycle’s already stirring, ...

FAIRFAX, Va. and PALO ALTO, Calif., April 10, 2025 /PRNewswire/ -- QBurst has announced the appointment of Arun Kumar Ramchandran ("Rak") as the new Chief Executive Officer. Multiples Alternate Asset ...

We recently published a list of the 10 High Growth Forever Dividend Stocks to Invest In. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other ...

South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination ... and former Vertex Pharmaceuticals scientist Kyu Baek. The ...

December 31, 2024, with projected cash runway into late 2027 SAN DIEGO, March 26, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company ...

RBC Capital initiated coverage of Ascendis Pharma (ASND) with an Outperform rating and $205 price target. The stock has outperformed the ...